More recently several reports have linked resistance to B-RAF inhibitors with induced glutamine dependency in melanoma cells32–35, suggesting that altered metabolisms and energy sources may be central to acquire drug resistance in some cancers including melanoma. This evidence concerns the gene BRAF and melanoma.